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A phenanthridine derivative covalently linked to a ruthenium
complex yields an imaging probe whose ﬂuorescence intensity
and lifetime change substantially in the presence of RNA.
Time-resolved detection is emerging as an attractive approach
in cellular imaging that can overcome the low signal to
background (S/B) ratios caused by autoﬂuorescence.1 To take
advantage of this technique there is a need for molecular
probes exhibiting relatively long-lived emission lifetimes
(410 ns) that are longer than the lifetimes of autoﬂuorescence
typical of cells. Among probes with such lifetimes, phenan-
thridine derivatives, such as ethidium bromide and propidium
iodide (PI), are probably the most widely used for detecting
the presence of duplex nucleic acids.2 When bound to duplex
DNA or RNA, the ﬂuorescence intensity of these probes
increases greater than 20-fold and their lifetimes increase
to about 20 ns.3,4 Fluorescence lifetimes of 20 ns, though
longer-lived than cellular autoﬂuorescence, are still not
suﬃciently long to take full advantage of time-resolved detection
techniques where lifetimes of 4100 ns are desired.
However, among nucleic acid probes, very few have been
shown to exhibit lifetimes of the order of 100 ns, with an
important exception being ruthenium and lanthanide metal
ligand complexes.5–7 These complexes commonly exhibit
lifetimes extending into the microsecond time domain. As
such, they are ideal probes for time-resolved detection since
virtually all autoﬂuorescence signals have decayed at these
relatively long time scales.
In this report, we describe the properties of an RNA
probe, RuEth, that is composed of a phenanthridine moiety
covalently linked to a ruthenium(II) isothiocyanate modiﬁed
complex, RuITC (Fig. 1). RuEth was obtained by the reaction
of RuITC with an amine functionalized ethidium derivative8
(ESIw). RuEth possesses attractive advantages such as
RNA binding, ﬂuorescence intensity enhancement properties
of phenanthridine derivatives, and the longer ﬂuorescence
lifetimes of ruthenium bipyridine complexes through a
spin-forbidden resonance energy transfer (SF-RET) process.9
These features make RuEth an excellent probe for RNA
detection using time-resolved ﬂuorescence spectroscopy.
Using a combination of steady-state and time-resolved
spectroscopic techniques, the luminescence properties of
RuEth were examined and evaluated. Additionally, uptake
into mammalian cells was demonstrated through confocal
imaging and is shown to give the greatest signal in regions
of cells where RNA is known to localize.
The absorption spectrum of RuEth in Fig. 2 shows the
absorption due to the RuITC MLCT with a lmax of 458 nm in
the visible, with a broad phenanthridine absorption with a
lmax centred at 530 nm. Even though they are covalently
linked, both ﬂuorophores retain their individual absorption
characteristics. The spectral overlap between the emission of
RuITC (donor, Fig. 3a) and absorption of the phenanthridine
intercalator (acceptor) is favourable for resonance energy
transfer to take place. Such an energy transfer process to
the phenanthridine intercalator has already been observed
for another RNA probe that links ﬂuorescein to the same
intercalator.10 The novelty of the RuEth probe resides in its
ability to undergo SF-RET,7 a process that occurs with a
relatively slow energy transfer rate constant, making energy
transfer the lifetime limiting step of the ﬂuorescence of the
phenanthridine intercalator.
In order to show the eﬀect of RNA on the emissive properties
of the uncoupled complex, RuITC, spectra were obtained in
solutions with and without Turolla yeast RNA. The spectra of
RuITC in those two environments can be seen in Fig. 3a.
The spectrum of RuITC was essentially identical in both
environments, except that in the presence of RNA, there was
Fig. 1 The chemical structures of ruthenium isothiocyanate (RuITC)
and the RNA probe RuEth.
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a slight increase in intensity. The RuEth complex, on the other
hand, exhibited signiﬁcant spectral changes when RNA is
introduced to the sample (Fig. 3b). When no RNA is present,
the emission intensity is much less intense than that of
RuITC, which is a consequence of eﬃcient SF-RET to the
neighbouring phenanthridine group. Moreover, the ﬂuores-
cence of the phenanthridine derivative is basically absent, since
the phenanthridine excited state is eﬃciently quenched when in
an aqueous environment. Upon addition of RNA to the
solution, however, there is an order of magnitude increase in
the emission intensity. The quantum yield for RuEth was
found to be 0.016  0.004 and 0.16  0.004 in the absence
and presence of RNA, respectively. Furthermore, the
spectrum resembles that of the phenanthridine intercalator
rather than RuITC. This result is indicative of the protection
of the phenanthridine moiety from the aqueous environment
by binding to the RNA polynucleotide.
To further characterize the ﬂuorescence properties of
RuEth, time-resolved emission studies were conducted. In
the presence of RNA, RuITC exhibited a two-component
lifetime of 347  10 ns (78%) and 676  10 ns (22%). RuEth
also exhibited a two-component lifetime, but with values of
96  10 ns (88%) and 319  10 ns (12%). The 96 ns
component can be attributed to ﬂuorescence from the
intercalator, while the longer-lived emissive signal comes from
the RuITC moiety. In solutions which contained no RNA,
RuEth had a single component lifetime of 437  10 ns.
The measured four-fold increase in the intercalator lifetime
(96  10 ns) compared to other phenanthridine derivatives
(20 ns) is consistent with SF-RET from the ruthenium
complex, which makes it especially useful for time-resolved
detection in complex biological solutions, such as cell growth
medium (CGM).7 The autoﬂuorescence of these solutions
often overlaps with that of the probe, leading to poor S/B
ratios when detected using steady-state ﬂuorescence methods.
In CGM, the steady-state S/B ratio of RuEth on addition
of RNA was 3. Using the time-resolved method, which
monitored the signal 20 ns after excitation, the S/B ratio was
now increased to over 13 (Fig. 4). Such an increase in the S/B
ratio occurs because in the time window monitored, the
emission signal from the CGM has already decayed leaving
only the signal from RuEth.
The aﬃnity for duplex RNA and the ability to undergo
ﬂuorescence switching should make RuEth a suitable probe
for in vivo imaging in cells. To test the validity of this
possibility, the ability of RuEth to image mammalian breast
cancer cells was evaluated. When the resulting emission of
RuEth is imaged, as shown in Fig. 5b, it is apparent that
ﬂuorescence intensity is localized within certain cellular
regions, when a comparison with the optical image (Fig. 5a)
is done. Given the aﬃnity of RuEth towards RNA, then
Fig. 2 Absorption spectra of RuITC (2.0 mM) and RuEth (2.0 mM) in
tris buﬀer pH 7.5.
Fig. 3 Emission spectra of (a) RuITC (2.0 mM) and (b) RuEth
(2.0 mM) in the presence and absence of Turolla yeast RNA.
(lexc = 450 nm)
Fig. 4 Time-resolved emission spectra of RuEth (0.2 mM) in cell
growth medium (CGM) with (blue, green) and without (red, black)
Turolla yeast RNA. lexc = 450 nm.
Fig. 5 Optical (a) and ﬂuorescence (b) microscope images of RuEth
uptake into mammalian cells.
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regions exhibiting the greatest intensities should be those rich
in polyribonucleotides. This is evident in the ﬂuorescent image
because the probe intensity is less in the nucleus, which
contains DNA, than it is in the surrounding cytoplasm where
mRNA is likely to be present. Furthermore, in the nucleolus
(a dense region of RNA in the nucleus) the intensity of RuEth
was found to be at a maximum.
In conclusion, by simply coupling RuITC to a phenanthridine
ﬂuorophore to produce RuEth we were able to create a RNA
probe whose luminescence properties possibly make it superior
to other probes for the detection of RNA under certain
conditions. RuEth undergoes a nine-fold increase in signal
intensity and has a ﬂuorescence lifetime over times greater
than other phenanthridine derivatives in the presence of RNA.
Additionally, due to the relatively long-lived ﬂuorescence, the
S/B ratio can be increased from 3 to 13 using the time-resolved
detection technique, in a complex biological solution. Cell
imaging also shows the potential of RuEth to be employed as
an in vivo probe for RNA. Studies on the binding of DNA with
this probe are ongoing and will be shown in future work.
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